Robuta

https://www.news-medical.net/news/20250929/Five-session-SBRT-reduces-side-effects-in-intermediate-risk-prostate-cancer.aspx Five-session SBRT reduces side effects in intermediate-risk prostate cancer Sep 29, 2025 - For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to... side effectsintermediate riskfivesessionsbrt https://ancan.org/event/intermediate-risk-prostate-cancer-3/2026-04-27/ Low/Intermediate Risk Prostate Cancer | AnCan THE HOME OF PEER-TO-PEER VIRTUAL SUPPORT GROUPS low intermediateprostate cancerriskancan https://research.ibm.com/publications/proteomic-based-stratification-of-intermediate-risk-prostate-cancer-patients Proteomic-based stratification of intermediate-risk prostate cancer patients for Life Science... Proteomic-based stratification of intermediate-risk prostate cancer patients for Life Science Alliance by Qing Zhong et al. patients for lifeintermediate risk https://www.emjreviews.com/en-us/amj/urology/abstract/the-international-bladder-cancer-group-intermediate-risk-non-muscle-invasive-bladder-cancer-scoring-system-predicts-the-need-for-intervention-for-patients-on-active-surveillance-j180123/ The International Bladder Cancer Group Intermediate-Risk Non-muscle Invasive Bladder Cancer Scoring... May 16, 2024 - Patients with low-grade (LG) Ta non-muscle invasive bladder cancer (NMIBC) exhibit a high recurrence rate, while cancer-specific... the internationalbladder cancerintermediate riskgroup https://digitalcommons.library.tmc.edu/baylor_docs/3062/ "Treatment of High- and Intermediate-High-Risk Pulmonary Embolism by th" by Arkadiusz Pietrasik,... BACKGROUND: Multidisciplinary Pulmonary Embolism Response Teams (PERTs) were established to individualize the treatment of high-risk (HR) and... intermediate risk https://ancan.org/event/intermediate-risk-prostate-cancer/2022-09-12/ Low/Intermediate Risk Prostate Cancer | AnCan THE HOME OF PEER-TO-PEER VIRTUAL SUPPORT GROUPS low intermediateprostate cancerriskancan https://www.sfa-phrt.ch/projects/education/stratifying-intermediate-risk-prostate-cancer-subtypes-by-complex-centric-mass-spectrometry-based-proteome-analysis/ Stratifying Intermediate-Risk Prostate Cancer Subtypes by Complex-Centric Mass Spectrometry-based... intermediate riskprostate cancer https://ppcp.mirrorsmed.org/en/topic/px0g35gvji804800wk84o88s88o8kgw PinPointcases - Low- and intermediate-risk NMIBC: surveillance or intravesical therapy? intermediate risklowsurveillancetherapy https://augusta.elsevierpure.com/en/publications/pathologic-upgrading-in-favorable-intermediate-risk-active-survei/ Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical... intermediate riskactive surveillancepathologicupgradingfavorable https://www.radcliffecardiology.com/webinars/landmark-data-intermediate-pe-hi-peitho-and-clinical-implications Intermediate-risk PE: HI-PEITHO Webinar Insights intermediate riskpehiwebinarinsights https://diversification.com/mutual-funds/PCFCX PIMCO California Intermediate Municipal Bond Fd Cl C (PCFCX) | Forecast, Risk & Portfolio Analysis PIMCO California Intermediate Municipal Bond Fund Class C is an actively managed municipal bond mutual fund focused on generating high current income that is... https://www.news-medical.net/news/20250929/Five-session-SBRT-reduces-side-effects-in-intermediate-risk-prostate-cancer.aspx Five-session SBRT reduces side effects in intermediate-risk prostate cancer Sep 29, 2025 - For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to... side effectsintermediate riskfivesessionsbrt https://scholars.duke.edu/grant/254994 Scholars@Duke grant: BBI Ph1 TP-3654 and Ruxolitinb in patients with Intermediate and High Risk... https://ancan.org/event/intermediate-risk-prostate-cancer-3/2026-04-27/ Low/Intermediate Risk Prostate Cancer | AnCan THE HOME OF PEER-TO-PEER VIRTUAL SUPPORT GROUPS low intermediateprostate cancerriskancan https://pubmed.ncbi.nlm.nih.gov/25633724/?dopt=Abstract Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications... The Bova risk score accurately stratifies normotensive patients with acute PE into stages of increasing risk of PE-related complications that occur within 30... https://www.linkos.cz/lekar-a-multidisciplinarni-tym/kongresy/po-kongresu/databaze-tuzemskych-onkologickych-konferencnich-abstrakt/health-related-quality-of-life-in-newly-diagnosed-low-risk-and-intermediate-1-ri/ Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on... https://research.ibm.com/publications/proteomic-based-stratification-of-intermediate-risk-prostate-cancer-patients Proteomic-based stratification of intermediate-risk prostate cancer patients for Life Science... Proteomic-based stratification of intermediate-risk prostate cancer patients for Life Science Alliance by Qing Zhong et al. patients for lifeintermediate risk https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2638/spaceit-hydrogel-system-perirectal/?qd=38845097 SpaceIT Hydrogel System for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate... New life-saving treatments for Prostate cancer in clinical trial on SpaceIT Hydrogel System for Perirectal Spacing in Subjects with Low to Intermediate Risk...